Valeritas' Series C Round

Valeritas raised a round of funding on September 12, 2011.

Valeritas is committed to developing and commercializing treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type 2 diabetes…

Articles about Valeritas' Series C Round: